Vir Biotechnology (VIR) Payables (2018 - 2025)
Historic Payables for Vir Biotechnology (VIR) over the last 8 years, with Q3 2025 value amounting to $6.8 million.
- Vir Biotechnology's Payables fell 626.97% to $6.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.8 million, marking a year-over-year decrease of 626.97%. This contributed to the annual value of $5.1 million for FY2024, which is 1978.21% down from last year.
- According to the latest figures from Q3 2025, Vir Biotechnology's Payables is $6.8 million, which was down 626.97% from $12.2 million recorded in Q2 2025.
- In the past 5 years, Vir Biotechnology's Payables registered a high of $12.4 million during Q2 2023, and its lowest value of $2.7 million during Q3 2022.
- For the 5-year period, Vir Biotechnology's Payables averaged around $7.2 million, with its median value being $6.5 million (2021).
- Its Payables has fluctuated over the past 5 years, first plummeted by 8028.03% in 2021, then soared by 19600.11% in 2022.
- Quarter analysis of 5 years shows Vir Biotechnology's Payables stood at $6.5 million in 2021, then dropped by 1.52% to $6.4 million in 2022, then fell by 1.37% to $6.3 million in 2023, then decreased by 19.78% to $5.1 million in 2024, then skyrocketed by 34.76% to $6.8 million in 2025.
- Its Payables stands at $6.8 million for Q3 2025, versus $12.2 million for Q2 2025 and $3.7 million for Q1 2025.